¥11,630.00 ($73.69)

-180.00 (-1.52%)

Weekly Expected Move ±3.6%

¥10787 ¥11208 ¥11630 ¥12052 ¥12473

JPX · Healthcare · Medical - Devices · Tech Score Neutral · Power 42 · ¥314.2B mcap · 8M float · 0.625% daily turnover

Revenue

$139.0B -0.9% ▼

5Y CAGR: +0.8%

Gross Profit

$73.8B -0.8% ▼

5Y CAGR: +6.4%

Operating Income

$25.9B -2.4% ▼

5Y CAGR: +14.3%

Net Income

$18.6B -0.5% ▼

5Y CAGR: +14.1%

EPS (Diluted)

$645.39 +3.7% ▲

5Y CAGR: +15.3%

EBITDA

$37.7B +2.7% ▲

5Y CAGR: +11.2%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$146.8B	$132.1B	$134.6B	$140.3B	$139.0B
YoY Growth	+10.0%	-10.0%	+1.9%	+4.2%	-0.9%
Cost of Revenue	$84.7B	$64.5B	$64.2B	$65.9B	$65.2B
Gross Profit	$62.1B	$67.6B	$70.4B	$74.4B	$73.8B
Gross Margin	42.3%	51.2%	52.3%	53.1%	53.1%
R&D Expenses	$3.3B	$3.4B	$3.8B	$4.7B	$4.2B
SG&A Expenses	$37.5B	$41.4B	$40.7B	$43.2B	$47.9B
Operating Expenses	$42.3B	$44.9B	$46.3B	$47.9B	$47.9B
Operating Income	$19.8B	$22.7B	$24.1B	$26.5B	$25.9B
Operating Margin	13.5%	17.2%	17.9%	18.9%	18.6%
Interest Expense	$39M	$37M	$37M	$34M	$50M
Income Before Tax	$21.0B	$23.7B	$25.2B	$27.0B	$27.1B
Tax Expense	$6.3B	$7.5B	$7.9B	$8.3B	$8.5B
Net Income	$14.7B	$16.2B	$17.3B	$18.7B	$18.6B
Net Margin	10.0%	12.3%	12.8%	13.3%	13.4%
EPS (Diluted)	$486.67	$536.21	$571.23	$622.44	$645.39
EBITDA	$29.4B	$32.8B	$34.6B	$36.7B	$37.7B
Shares Outstanding	30M	30M	30M	30M	29M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$34.0B	$35.1B	$39.6B	$30.4B	$34.4B	$34.0B	$40.8B	$31.0B
Cost of Revenue	$16.3B	$16.6B	$18.1B	$13.6B	$15.8B	$16.3B	$17.5B	$14.2B
Gross Profit	$17.7B	$18.5B	$21.6B	$16.8B	$18.7B	$17.7B	$23.3B	$16.8B
Gross Margin	52.0%	52.7%	54.4%	55.4%	54.2%	52.1%	57.1%	54.3%
R&D Expenses	$0	$0	$4.2B	$0	$0	$0	$0	$0
SG&A Expenses	$11.5B	$11.7B	$13.1B	$12.6B	$12.2B	$12.0B	$13.1B	$12.2B
Operating Expenses	$11.5B	$11.7B	$13.1B	$12.6B	$12.2B	$12.0B	$13.1B	$12.2B
Operating Income	$6.1B	$6.7B	$8.5B	$4.2B	$6.5B	$5.7B	$10.2B	$4.6B
Operating Margin	18.1%	19.2%	21.4%	13.8%	18.8%	16.8%	25.0%	14.8%
Interest Expense	$11M	$10M	$20M	$14M	$14M	$9M	$20M	$16M
Income Before Tax	$6.7B	$6.8B	$9.0B	$4.4B	$6.6B	$5.9B	$10.2B	$4.9B
Tax Expense	$2.0B	$2.1B	$2.7B	$1.5B	$1.9B	$1.7B	$3.1B	$1.9B
Net Income	$4.7B	$4.7B	$6.2B	$2.8B	$4.7B	$4.1B	$7.1B	$3.1B
Net Margin	13.8%	13.3%	15.7%	9.3%	13.8%	12.2%	17.3%	9.9%
EPS (Diluted)	$162.18	$161.91	$216.14	$100.87	$174.17	$151.92	$258.25	$113.97
EBITDA	$9.3B	$9.2B	$11.4B	$7.2B	$9.5B	$8.7B	$13.4B	$7.7B
Shares Outstanding	30M	29M	29M	28M	27M	27M	27M	27M

6960.T JPX